Diabetes mellitus (DM) is a strong risk factor for cardiovascular morbidity and mortality. It is suggested that both hypertension and DM may synergistically affect left ventricular (LV) structure and function. To assess whether hypertensive patients with DM have more depressed LV function in terms of long axis and midwall function by use of tissue Doppler echocardiogram than do patients with hypertension only. Hypertensive patients (n=200) and hypertensive patients with DM (n=60), all of whom had normal LV ejection fraction, were recruited for the study. Healthy age-and sex-matched subjects (n=20) served as the control group. Echocardiography was performed including LV wall thickness, dimension, Doppler, and tissue Doppler imaging. Blood pressure (BP) was measured in the supine position before and after echocardiographic examination. The hypertensive patients with or without DM had higher BP and LV wall thickness, had more decreased afterload measured by meridional end-systolic stress, and had more depressed LV diastolic, long axis, and global function than did the controls. There was no difference in LV function between the hypertensive patients with and without DM. The hypertensive patients with or without DM had depressed LV function compared with the controls, but there was no difference between the hypertensive patients with or without DM. DM does not seem to have additive adverse effects on the LV long axis and midwall function in persons with hypertension.
Introduction
Diabetes mellitus (DM) and hypertension both contribute to cardiovascular disease leading to atherosclerosis, ischemic heart disease, and heart failure. Hypertension is often associated with impaired glucose tolerance and insulin resistance and is not uncommonly combined with DM. 1 Hypertension and DM are continuously increasing in the general population and are associated with adverse remodeling of the cardiovascular system. 2 This high risk for progressive adverse effects on the heart from the preclinical phase has resulted in novel American College of Cardiology/ American Heart Association (ACC/AHA) guidelines for the classification of heart failure, which include stage A and B before overt heart failure symptoms develop. 3 DM can affect cardiac structure and function in the absence of ischemic heart disease or hypertension. 4 This condition, also known as diabetic cardiomyopathy, 5 is often characterized by left ventricular (LV) hypertrophy and diastolic dysfunction, which can be easily detected by using Doppler echocardiography. Elevated blood pressure itself typically affects the heart, and it is commonly associated with increased LV mass, LV dilatation, diastolic dysfunction, reduced chamber compliance, and progression to overt heart failure. 
Materials and Methods
Patients with hypertension who had been treated with antihypertensive drugs and who had not changed during the previous 6 months were enrolled. Excluded from the study were those (1) who had a history of previous coronary artery disease or with endovascular intervention, bypass surgery, or who had regional wall motion abnormalities; (2) who had undergone open heart surgery; (3) who had significant valvular heart disease or other structural heart diseases, including congenital heart disease, hypertrophic cardiomyopathy, dilated cardiomyopathy, or low LV ejection fraction less than 45%; and (4) who had an electrocardiographically evident left bundle branch block, preexcitation, or atrial fibrillation.
The hypertensive patients were divided into 2 groups:
the hypertension group with hypertension only and the hypertension with DM group. Age-and sex-matched healthy controls who had normal blood pressure (BP), no medical history of cardiovascular disease, a normal electrocardiogram, and no remarkable organic heart disease on echocardiography were also enrolled. Demographic data were obtained before echocardiography. BP was measured in the supine position before and after echocardiographic examination. All subjects gave informed consent and all examinations were approved by the Institutional Review Board. In the presence of altered LV geometry, as in hypertension, systolic shortening measured at the level of the endocardium is often higher than predicted from the measured level of end-systolic stress (ESS). 12 In contrast, when measured at the midwall level, systolic shortening is often depressed. 13, 14 Thus, midwall FS was calculated as described previously elsewhere.
Echocardiographic examination
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The force-limiting LV ejection (i.e., chamber function) is myocardial afterload, which can be measured as wall stress at end-systole according to the principles of Laplace's law. 15 Longitudinal myocardial fiber shortening is limited by longitudinal (meridional) ESS. This meridional ESS 13, 16 was calculated as: 
Results
Clinical characteristics
As shown in Table 1 , hypertensive patients (n=200), hypertensive patients with DM (n=60), and age-, and sex-matched controls (n=20) were enrolled. The hypertensive patients with or without DM had higher body mass index, systolic and diastolic BP, and pulse pressure than did the healthy controls. On average, the duration of hypertension was 7.7 years in hypertension group and 6.0 years in the hypertension with DM group. The DM patients had the disease for 7 years on average. Among the antihypertensive drugs, angiotensin-converting enzyme inhibitor and/or angiotensin-receptor blocker was more commonly used in the hypertension with DM group than in the hypertension group (65% vs 47%).
There were no differences in age, sex, current smoking, or heart rate between the study groups.
Echocardiographic parameters of LV function
The hypertensive patients with or without DM had higher IVSd, LV mass index, and relative wall thickness than did the control group, but not LV dimension, FS, or ejection fraction ( Table 2 ). The patients with hypertension had lower meridional ESS than did the controls. Of the diastolic function parameters, DT, isovolu- E/E', ratio of mitral inflow early (E) velocity to early diastolic mitral annular (E') velocity; r, Pearson correlation coefficient; B, logistic coefficient; LV, left ventricular; ACEi/ARB, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker. DM, diabetes mellitus; IVSd, end-diastolic interventricular septal thickness; LV, left ventricular; FS, fractional shortening; ESS, end-systolic stress; IVRT, isovolumic relaxation time; E/A, ratio of mitral inflow early (E) velocity to late (A) velocity; E', early diastolic mitral annular velocity; S', systolic mitral annular velocity; E/E', ratio of mitral inflow early (E) velocity to E' velocity. *p＜0.05 vs control, † p＜0.01 vs control.
mic relaxation time, and E/E' ratio were higher in the hypertensive patients than in the control group. The hypertensive patients had lower E' velocity, E/A ratio, and Tei index than did the controls.
Clinical correlates of echocardiographic parameters of LV diastolic function
We tested univariate analysis with the clinical and echocardiographic variables that can affect the LV diastolic function (Table 3 ). E/E' ratio, as a marker of LV filling pressure, showed good correlations with age, systolic BP, pulse pressure, relative wall thickness, and LV mass index. On multivariate analysis among the clinical and echocardiographic parameters, age and LV mass index were independent predictors of LV diastolic dysfunction.
Discussion
In this study, we observed that the hypertensive patients with or without DM had increased LV mass and depressed diastolic, long axis, and global LV function compared with the healthy controls, but no differences were noted between the hypertension and the hypertension with DM groups.
Increased LV mass or LV hypertrophy is a common finding in patients with hypertension and/or DM and is an independent risk factor for developing adverse cardiovascular events and progression to heart failure. [17] [18] [19] [20] High BP and obesity, which often coexist with DM, tend to be associated with preclinical cardiovascular abnormalities and may contribute to the association of diabetes with cardiovascular events. In this study, the patients with hypertension had higher body mass index, BP, and pulse pressure than did the healthy controls.
These characteristics in the hypertensives led to higher LV mass and more depressed LV function, but with preserved LV systolic function. Diastolic dysfunction with preserved LV systolic function is a common finding in patients with hypertension and DM even though they do not show any heart failure symptoms. In this study, we did not try to assess heart failure symptoms and excluded the patients with past coronary heart disease, significant arrhythmia, valvular heart disease, or systolic dysfunction. In the real world, however, there may be a much higher prevalence of overt and preclinical cardiovascular diseases in patients with hypertension and/or DM. Furthermore, those hypertensive patients with subclinical diastolic and long axis dysfunction as in this study should be managed and followed up for future adverse cardiovascular events.
In our study, there were no differences in LV function between the hypertension and the hypertension with DM groups, which suggests that DM might not have additive adverse effects on LV function in patients with hypertension. Only age and LV mass are independent predictive factors of LV diastolic function. But we should take into account multiple complicated variables in claiming a potential link to cardiac structure and function, and it is difficult to conclude such a link in this small observational study.
In conclusion, the hypertensive patients with or without DM had higher LV mass and depressed LV diastolic, long axis, and global function compared with the healthy controls, but there was no difference between the hypertension and the hypertension with DM groups.
First, this study is cross-sectional and observational and had a relatively small number of participants in a single center. Prospective studies with larger populations will be needed for determining clinical implication. Second, we did not assess more complicated clinical variables that can be associated with depressed LV function.
